How to Take Colchicine: Dosage, Timing, and Interactions

Colchicine is one of the oldest anti-inflammatory drugs still in regular use, and how you take it matters enormously because the gap between a helpful dose and a harmful one is unusually small. For an acute gout flare, the current standard is a low-dose regimen: 1.2 mg at the first sign of a flare, followed by 0.6 mg one hour later. For long-term prevention or other conditions like pericarditis, the typical maintenance dose is 0.5 to 0.6 mg once or twice daily. But those numbers shift depending on your kidney function, your body weight, and especially what other medications you take, because certain common drugs can push colchicine levels into dangerous territory.

Why the Dose Matters More Than Usual

Colchicine has what pharmacologists call a narrow therapeutic index, meaning the dose that works and the dose that causes serious harm are not far apart. There is no clean boundary between safe, toxic, and lethal amounts, which creates real confusion even among prescribers.¹ The drug works by disrupting structures inside cells called microtubules, which in turn dials down several inflammatory pathways, including the machinery that drives the intense pain of a gout attack.² It also blocks a key inflammation trigger known as the NLRP3 inflammasome, which is why it has found uses well beyond gout.³ The challenge is that the same mechanism that calms inflammation can, at higher concentrations, damage healthy tissue throughout the body.

Dosing for an Acute Gout Flare

For decades, the traditional advice for a gout attack was to take colchicine every hour or two until the pain stopped or diarrhea set in, whichever came first. That approach has been largely abandoned. A landmark trial compared low-dose colchicine (1.2 mg followed by 0.6 mg one hour later, for a total of 1.8 mg) against high-dose colchicine (1.2 mg followed by 0.6 mg every hour for six hours, totaling 4.8 mg) and found that both regimens worked about equally well: roughly a third of patients in each group had a meaningful reduction in pain within 24 hours, compared to about 16 percent on placebo.⁴ The difference was in side effects. In the high-dose group, about 77 percent of patients developed diarrhea, nearly one in five had severe diarrhea, and roughly one in six vomited. In the low-dose group, diarrhea occurred in about 23 percent of patients, no one had severe diarrhea, and no one vomited. The side-effect profile for low-dose colchicine was statistically indistinguishable from placebo.⁵

Timing is critical for acute flares. The low-dose regimen works best when started within 12 hours of symptom onset. If you wait a full day, the benefit drops considerably. This means keeping colchicine on hand if you have a history of gout, so you can take it at the very first twinge of joint pain rather than waiting for a prescription to be filled.

Prophylactic and Maintenance Dosing

When you start a urate-lowering drug like allopurinol or febuxostat to manage chronic gout, there is a frustrating paradox: the medication that is supposed to prevent gout attacks can actually trigger them in the first several months. Low-dose colchicine taken daily during this transition period cuts the number of flares dramatically. In a controlled trial, patients who took prophylactic colchicine while starting allopurinol averaged about 0.5 flares over six months, compared to nearly 3 flares without it. The flares that did occur were also milder.⁶ The standard prophylactic dose is 0.5 mg once or twice daily, maintained for at least three to six months after urate levels reach target.⁷

For Familial Mediterranean Fever (FMF), a genetic condition involving recurrent episodes of fever and inflammation, colchicine is taken daily on an ongoing basis, often at doses of 1 to 2 mg per day. Consistent daily use is what matters here. A study in an endemic region found that patients who took colchicine regularly had fewer attacks, and regular use was independently linked to a higher daily dose, suggesting that people on adequate doses felt the benefit and stayed on the drug.⁸ In FMF, the stakes of stopping are real: unchecked inflammation over years can lead to amyloidosis, a serious complication involving protein deposits in the kidneys.

Beyond Gout and FMF

Colchicine has expanded into cardiovascular medicine, particularly for pericarditis, the inflammation of the sac surrounding the heart. In a trial published in the New England Journal of Medicine, patients with acute pericarditis who received colchicine on top of standard anti-inflammatory treatment (aspirin or ibuprofen) had fewer recurrences than those on placebo. The dosing for pericarditis was 0.5 mg twice daily for three months in patients over 70 kg, and 0.5 mg once daily in those weighing 70 kg or less.⁹ This weight-based adjustment is worth noting because it is one of the few places where body weight explicitly changes the recommended colchicine dose.

When and How to Take It

After swallowing a tablet, colchicine reaches peak blood levels in about an hour.¹⁰ Bioavailability is moderate and quite variable from person to person, with estimates ranging from about 25 to nearly 90 percent of the dose actually reaching the bloodstream.¹¹ This variability is one reason why the same dose can be fine for one person and problematic for another.

Colchicine can be taken with or without food. Many people find that taking it with a meal or a glass of water reduces stomach upset, which is the most common side effect even at recommended doses. For prophylactic use, taking it at the same time each day helps maintain consistent drug levels. If you miss a dose of your daily maintenance regimen, take it when you remember, but do not double up.

Drug Interactions That Can Be Dangerous

This is arguably the most important section for anyone taking colchicine. The drug is broken down in the body primarily by an enzyme called CYP3A4 and is also pumped out of cells by a transporter called P-glycoprotein (P-gp). Drugs that block either of these pathways can cause colchicine to accumulate to toxic levels, even when you are taking a standard dose.¹² The combination of CYP3A4 and P-gp inhibition is particularly dangerous because it hits both pathways at once.

Some of the most problematic interacting drugs include:

Clarithromycin: This commonly prescribed antibiotic is a potent inhibitor of both CYP3A4 and P-gp. Case reports describe colchicine toxicity mimicking septic shock in patients who were prescribed clarithromycin while on regular colchicine, even when kidney and liver function were normal.¹³ Erythromycin poses a similar risk.
Azole antifungals: Ketoconazole, itraconazole, and similar drugs are strong CYP3A4 inhibitors and can sharply raise colchicine levels.
Cyclosporine: Used in transplant patients and some autoimmune conditions, cyclosporine inhibits both CYP3A4 and P-gp.
HIV protease inhibitors: Ritonavir and related drugs are among the most potent CYP3A4 inhibitors available.
Grapefruit juice: In large amounts, grapefruit inhibits intestinal CYP3A4 and could modestly increase colchicine absorption. The risk is lower than with prescription inhibitors, but it is worth mentioning to your doctor if you drink it regularly.

When you must use colchicine alongside a moderate CYP3A4 or P-gp inhibitor, prescribers typically cut the colchicine dose. With strong inhibitors of both pathways, current guidelines recommend against using colchicine at all, particularly if you also have kidney or liver problems. The issue is that these interactions are frequently overlooked or misunderstood. A review in Drug Safety found that errors in managing colchicine interactions are common and called for clearer evidence-based guidance.¹²

The Statin Question

Since colchicine has moved into cardiovascular medicine and statins are among the most widely prescribed drugs on the planet, the overlap between the two is enormous. This creates a specific concern: muscle toxicity. Statins on their own can cause muscle problems in some people, and colchicine can do the same. Together, the risk appears to multiply. A systematic review found that among patients who developed adverse events on the combination, about two-thirds experienced myopathy (muscle weakness and pain) and about a quarter developed rhabdomyolysis, a potentially life-threatening breakdown of muscle tissue.¹⁴

An analysis of the FDA’s adverse event database found strong signals for toxic myopathy, rhabdomyolysis, and other muscle-related harms when colchicine and statins were used together.¹⁵ Atorvastatin and rosuvastatin were specifically flagged in a separate database study as having interaction signals with colchicine for rhabdomyolysis.¹⁶ This does not mean you can never use both drugs. Many people do. But it means you should report any new muscle weakness, tenderness, or dark urine promptly, and your prescriber should be aware of the combination.

Side Effects and What to Watch For

The most common side effect of colchicine at any dose is diarrhea. At standard low doses, it is usually mild and resolves when the drug is stopped or the dose is reduced.¹⁷ Many people on chronic low-dose colchicine tolerate it well for years. In a study of FMF patients, about 19 percent experienced colchicine intolerance, with diarrhea being the most common reason (about 10 percent of the total group), followed by liver enzyme elevations in about 5 percent. Less common problems included low white blood cell counts, muscle damage, nausea, and skin rash.¹⁸

Toxicity from colchicine, whether from overdose or from drug interactions pushing levels too high, follows a recognizable pattern. Early symptoms in the first 10 to 24 hours are gastrointestinal: abdominal pain, nausea, vomiting, and diarrhea. Over the next one to seven days, multi-organ problems can develop, including bone marrow suppression, kidney failure, cardiac damage, confusion, and respiratory distress.¹ New Zealand’s drug safety authority notes that these delayed effects can include bone marrow depression and organ impairment.¹⁹ Recovery from a serious poisoning episode typically takes several weeks but is generally complete in those who survive. The critical thing to understand is that by the time the worst symptoms appear, the drug has already done its damage, so prevention through correct dosing and interaction avoidance is far more effective than treatment after the fact.

Kidney Disease and Dose Adjustments

Colchicine is partly cleared through the kidneys, so reduced kidney function allows it to accumulate. A pharmacokinetic modeling study spelled out the adjustments needed at different levels of impairment. For mild kidney impairment (roughly a 30 percent drop in clearance), a once-daily dose of 0.5 to 0.6 mg stays in the therapeutic range. The standard twice-daily dose of 0.6 mg, however, is projected to push levels about 23 percent above the upper safety limit. For moderate impairment, about 0.48 mg once daily keeps levels safe, while the standard 0.6 mg once daily exceeds the safe range by about 10 percent. For severe impairment, only 0.3 mg once daily stays within bounds; higher doses overshoot by 15 to 36 percent.²⁰

This is a practical problem because gout itself is closely tied to kidney function. Many gout patients have some degree of kidney impairment, which means they need colchicine the most but tolerate it the least. A study of patients with severe chronic kidney disease found that colchicine could be used for crystal-induced arthritis flares with dose reduction and close monitoring, but it requires careful attention.²¹ If you have kidney problems and are prescribed colchicine, make sure every prescriber you see knows your kidney function, particularly urgent-care or emergency physicians who may not have your full history.

Pregnancy, Fertility, and Breastfeeding

For people with FMF, the question of whether to continue colchicine during pregnancy comes up regularly. The evidence is reassuring. A systematic review and meta-analysis found no increased risk of miscarriage or fetal loss with colchicine use in FMF, with birth defect rates in exposed pregnancies ranging from about 0.6 to 4 percent, comparable to unexposed pregnancies. Fertility did not appear to be affected in either women or men, including sperm quality. One study on breastfeeding found no growth differences between exposed and unexposed babies.²² The current guidance from European rheumatology societies supports continuing colchicine during pregnancy and breastfeeding in FMF patients, since stopping the drug risks flares and long-term complications like amyloidosis. For other conditions where colchicine use is less essential, the risk-benefit conversation with a doctor is more nuanced.

Cost and Access Issues

Colchicine is derived from the autumn crocus plant and has been used for centuries, yet its price history in the United States is unusual. In 2009, the FDA granted market exclusivity to a branded version (Colcrys) after its manufacturer conducted the formal clinical trial demonstrating the low-dose regimen discussed earlier. Inexpensive generic versions were pulled from the market. A study in the Journal of General Internal Medicine found that after the FDA’s action, fewer gout and FMF patients started colchicine at all, and average monthly prescription costs rose substantially, from about $418 to $651 per patient.²³ Generics have since re-entered the market and prices have eased, but colchicine remains more expensive in the U.S. than in most other countries. If cost is a barrier, ask your pharmacist about generic options and manufacturer coupons.

Practical Tips for Staying Safe

Given colchicine’s narrow safety margin and its susceptibility to drug interactions, a few habits can reduce your risk of problems:

Keep an updated medication list: Show it to every prescriber, including dentists and urgent-care doctors. Antibiotics like clarithromycin are commonly prescribed for respiratory infections, and the prescriber may not know you take colchicine unless you tell them.
Start low for acute flares: Follow the low-dose protocol rather than taking repeated doses until symptoms stop. The old hourly-dosing method offers no extra benefit and dramatically increases side effects.
Watch for muscle symptoms: If you take a statin alongside colchicine, any new muscle pain, weakness, or unusually dark urine warrants a prompt call to your doctor.
Know your kidney function: If you have not had blood work recently, ask. Kidney function can change over time, and a dose that was safe two years ago may not be safe now.
Do not share or stockpile: The difference between a useful dose and a dangerous one depends on the individual’s kidney function, liver function, body weight, and other medications. A dose that is safe for you could be toxic for someone else in your household.

Colchicine toxicity is rare when the drug is used correctly, but when it happens, it tends to be severe. The gastrointestinal symptoms that come first can easily be mistaken for a stomach bug, delaying the recognition that something more serious is underway. Awareness of that pattern, stomach problems followed days later by more systemic illness, can be the difference between seeking help early and presenting too late.